EGFR and head and neck squamous cell carcinoma: However, Epidermal Growth Factor Receptor (EGFR) has been studied extensively, and it is known that it is upregulated in most (up to 90%) head and neck squamous cell carcinoma patients and is associated with a poor prognosis [12].